Durban – JSE Limited listed Aspen Pharmacare Holdings Limited (“Aspen”), a global specialty and branded pharmaceutical company, is celebrating its 14^th consecutive year of Group-wide participation in

��

Stephen Saad, Aspen Group Chief Executive said, “ Aspen has a track record of improving access to healthcare to all patients but more particularly the most vulnerable among us. This spirit of care extends beyond healthcare to many socio-economic development (“SED”) initiatives. We have so many challenges to address, that it can seem overwhelming. However, with one step at a time, we can move forward. Today, ��we celebrate serving more than 910 000 individuals through projects across more than 40 countries, and I honour our employees who are at the very heart of making a difference and who are the heroes of our Mandela Day programme. With every 10^th person in the world impacted by poverty^[1], we recognise that every effort, no matter how big or small, offers a promise of hope to those in need.”

��

“We remain committed to an unwavering humanitarian spirit and actions that demonstrate generosity, humility and care and encourage others to join us and help make a difference to the most vulnerable among us,” added Saad.

��

, recognised as the Group’s flagship SED campaign, was initiated in 2011 and has focused on partnering with worthy beneficiaries across the six continents where Aspen has a business presence. The programme has assisted in providing relief to abandoned, neglected, orphaned or abused babies, children and women; the elderly, hungry and homeless; individuals inflicted with mental wellness challenges; students who strive to achieve academically; those who are disabled; victims of political conflict; residents at social rehabilitation institutions; healthcare facility patients who need support and equipment; environmental and climate challenges; and inequality, among others.

��

^[1] https://ourworldindata.org/poverty

Johannesburg, South Africa – Aspen Pharmacare Holdings Limited (“Aspen”), a global multinational specialty pharmaceutical company, has presented a state-of-the-art high performance wheelchair to South African wheelchair tennis star Donald Ramphadi.

��

Ramphadi, a French-open double quads champion and a prominent figure in wheelchair tennis, reached his at the Australian Open Wheelchair Championships in January 2024. He is undeterred by his impaired mobility and his by the International Tennis Federation is testament to his talent.

��

On the occasion of the presentation, Stavros Nicolaou, Aspen Senior Executive Strategic Trade said, “Aspen is honoured to support Donald Ramphadi ahead of his 2024 season when he takes to international courts to defend his title at the Paris Paralympics in France, among many others. We also laud Donald for his nomination in the 2024 Sportsman of the Year with a Disability category. In recent years we recognized Donald’s exceptional athletic talent, his unwavering dedication to wheelchair tennis and his dreams of bringing back gold for South Africa. Aspen subsequently facilitated the customisation and provision of a state-of-the-art high performance wheelchair tailored to his unique requirements to assist him in reaching his athletic goals. This action endorses Aspen’s commitment to inclusivity, accessibility, and the empowerment of athletes with disabilities. It is also aligned to our philosophy of embracing sports, arts and culture as powerful unifiers to promote healthy lifestyles and reduce the disease burden on our healthcare system.”

��

An overjoyed Donald Ramphadi said, “I am so grateful for this generous donation from Aspen which is a major boost ahead of the 2024 Paris Paralympics in France. I’ve previously played in matches where I’ve had to retire my lead because of my wheelchair which naturally shattered many dreams. I’m excited about this wheelchair and I’m more determined than ever to up my game and take everything that I can in the upcoming tournaments that I compete in.”��

��

Johannesburg, South Africa – Aspen Pharmacare, Africa’s largest pharmaceutical company, has announced continued humanitarian support to Ukraine, confirming further donations of critical care products to treat hospitalized patients who have been impacted by the ongoing conflict in that country.

��

Stavros Nicolaou, Aspen Group Senior Executive Strategic Trade, said, “Aspen is highly sensitised to the human suffering that war and conflict brings and which has had a devastating impact on innocent civilians. We are pleased to announce that we are further extending our support to Ukrainian victims of the present-day conflict with much needed pharmaceutical products and we are in the process of despatching additional supplies of Fraxiparine (for emergency surgeries) and Alkeran (for cancer) to treat patients in Ukrainian hospitals. We remain committed to providing ongoing humanitarian relief to victims of both natural and manmade disasters as may be necessary.”

��

Aspen recently hosted His Excellency, former President of the Ukraine, Viktor Yushchenko during an official visit to South Africa. On this occasion he said, “I am deeply grateful to Aspen for the invaluable humanitarian support provided to the people of Ukraine at this very tragic time. Aspen has helped countless Ukrainians with generous donations of life-saving critical care medicines. Aspen’s ongoing support reaffirms their understanding of the horrors of war, and demonstrates their unwavering care for innocent patients who are in desperate need of pharmaceutical products. I thank Aspen for their contributions to date as well as their commitment to�� providing more products to treat our patients.”��

��

One of the more important initiatives in this humanitarian collaboration with Her Excellency Ambassador and Plenipotentiary of Ukraine to South Africa, Liubov Abravoitova, concerns donations of Alkeran primarily used for the treatment of paediatric cancer patients at the Odessa Filatov Institute of Ophthalmology. She said, “We thank Aspen for its solidarity with Ukrainian people and support to Ukraine with donations of life-saving medicines, as well as for its cooperation with the Embassy of Ukraine in South African in humanitarian projects.” Aspen’s latest Alkeran donation has been expedited specifically to assist in the treatment of a six year old patient who is at risk of losing her only eye.

��

In March 2022 Aspen dontated life-saving medicines for 62��000 surgeries in Ukraine and also helped to evacuate South African medical students who were stranded in war-torn Ukraine.